Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells

Human surfactant protein D (SP-D) belongs to the family of collectins that is composed of a characteristic amino-terminal collagenous region and a carboxy-terminal C-type lectin domain. Being present at the mucosal surfaces, SP-D acts as a potent innate immune molecule and offers protection against...

Full description

Bibliographic Details
Main Authors: Valarmathy Murugaiah, Chiara Agostinis, Praveen M. Varghese, Beatrice Belmonte, Salvatore Vieni, Fanan A. Alaql, Salman H. Alrokayan, Haseeb A. Khan, Anuvinder Kaur, Terry Roberts, Taruna Madan, Roberta Bulla, Uday Kishore
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01171/full
_version_ 1818314213956780032
author Valarmathy Murugaiah
Chiara Agostinis
Praveen M. Varghese
Praveen M. Varghese
Beatrice Belmonte
Salvatore Vieni
Fanan A. Alaql
Salman H. Alrokayan
Haseeb A. Khan
Anuvinder Kaur
Terry Roberts
Taruna Madan
Roberta Bulla
Uday Kishore
author_facet Valarmathy Murugaiah
Chiara Agostinis
Praveen M. Varghese
Praveen M. Varghese
Beatrice Belmonte
Salvatore Vieni
Fanan A. Alaql
Salman H. Alrokayan
Haseeb A. Khan
Anuvinder Kaur
Terry Roberts
Taruna Madan
Roberta Bulla
Uday Kishore
author_sort Valarmathy Murugaiah
collection DOAJ
description Human surfactant protein D (SP-D) belongs to the family of collectins that is composed of a characteristic amino-terminal collagenous region and a carboxy-terminal C-type lectin domain. Being present at the mucosal surfaces, SP-D acts as a potent innate immune molecule and offers protection against non-self and altered self, such as pathogens, allergens, and tumor. Here, we examined the effect of a recombinant fragment of human SP-D (rfhSP-D) on a range of breast cancer lines. Breast cancer has four molecular subtypes characterized by varied expressions of estrogen (ER), progesterone (PR), and epidermal growth factor (EGF) receptors (HER2). The cell viability of HER2-overexpressing (SKBR3) and triple-positive (BT474) breast cancer cell lines [but not of a triple-negative cell line (BT20)] was reduced following rfhSP-D treatment at 24 h. Upregulation of p21/p27 cell cycle inhibitors and p53 phosphorylation (Ser15) in rfhSP-D-treated BT474 and SKBR3 cell lines signified G2/M cell cycle arrest. Cleaved caspases 9 and 3 were detected in rfhSP-D-treated BT474 and SKBR3 cells, suggesting an involvement of the intrinsic apoptosis pathway. However, rfhSP-D-induced apoptosis was nullified in the presence of hyaluronic acid (HA) whose increased level in breast tumor microenvironment is associated with malignant tumor progression and invasion. rfhSP-D bound to solid-phase HA and promoted tumor cell proliferation. rfhSP-D-treated SKBR3 cells in the presence of HA showed decreased transcriptional levels of p53 when compared to cells treated with rfhSP-D only. Thus, HA appears to negate the anti-tumorigenic properties of rfhSP-D against HER2-overexpressing and triple-positive breast cancer cells.
first_indexed 2024-12-13T08:46:04Z
format Article
id doaj.art-e7a4cf46ac304622aec46bf9f5ca5cac
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T08:46:04Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e7a4cf46ac304622aec46bf9f5ca5cac2022-12-21T23:53:26ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-07-011110.3389/fimmu.2020.01171548401Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer CellsValarmathy Murugaiah0Chiara Agostinis1Praveen M. Varghese2Praveen M. Varghese3Beatrice Belmonte4Salvatore Vieni5Fanan A. Alaql6Salman H. Alrokayan7Haseeb A. Khan8Anuvinder Kaur9Terry Roberts10Taruna Madan11Roberta Bulla12Uday Kishore13Biosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United KingdomInstitute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo Garofolo, Trieste, ItalyBiosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United KingdomSchool of Biosciences and Technology, Vellore Institute of Technology, Vellore, IndiaTumor Immunology Unit, Human Pathology Section, Department of Health Sciences, University of Palermo, Palermo, ItalyDivision of General and Oncological Surgery, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, ItalyBiosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United KingdomDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi ArabiaDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi ArabiaBiosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United KingdomBiosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United KingdomDepartment of Innate Immunity, ICMR—National Institute for Research in Reproductive Health, Mumbai, IndiaDepartment of Life Sciences, University of Trieste, Trieste, ItalyBiosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United KingdomHuman surfactant protein D (SP-D) belongs to the family of collectins that is composed of a characteristic amino-terminal collagenous region and a carboxy-terminal C-type lectin domain. Being present at the mucosal surfaces, SP-D acts as a potent innate immune molecule and offers protection against non-self and altered self, such as pathogens, allergens, and tumor. Here, we examined the effect of a recombinant fragment of human SP-D (rfhSP-D) on a range of breast cancer lines. Breast cancer has four molecular subtypes characterized by varied expressions of estrogen (ER), progesterone (PR), and epidermal growth factor (EGF) receptors (HER2). The cell viability of HER2-overexpressing (SKBR3) and triple-positive (BT474) breast cancer cell lines [but not of a triple-negative cell line (BT20)] was reduced following rfhSP-D treatment at 24 h. Upregulation of p21/p27 cell cycle inhibitors and p53 phosphorylation (Ser15) in rfhSP-D-treated BT474 and SKBR3 cell lines signified G2/M cell cycle arrest. Cleaved caspases 9 and 3 were detected in rfhSP-D-treated BT474 and SKBR3 cells, suggesting an involvement of the intrinsic apoptosis pathway. However, rfhSP-D-induced apoptosis was nullified in the presence of hyaluronic acid (HA) whose increased level in breast tumor microenvironment is associated with malignant tumor progression and invasion. rfhSP-D bound to solid-phase HA and promoted tumor cell proliferation. rfhSP-D-treated SKBR3 cells in the presence of HA showed decreased transcriptional levels of p53 when compared to cells treated with rfhSP-D only. Thus, HA appears to negate the anti-tumorigenic properties of rfhSP-D against HER2-overexpressing and triple-positive breast cancer cells.https://www.frontiersin.org/article/10.3389/fimmu.2020.01171/fullinnate immunitysurfactant protein Dimmune surveillancebreast cancerhyaluronic acid
spellingShingle Valarmathy Murugaiah
Chiara Agostinis
Praveen M. Varghese
Praveen M. Varghese
Beatrice Belmonte
Salvatore Vieni
Fanan A. Alaql
Salman H. Alrokayan
Haseeb A. Khan
Anuvinder Kaur
Terry Roberts
Taruna Madan
Roberta Bulla
Uday Kishore
Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
Frontiers in Immunology
innate immunity
surfactant protein D
immune surveillance
breast cancer
hyaluronic acid
title Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
title_full Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
title_fullStr Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
title_full_unstemmed Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
title_short Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
title_sort hyaluronic acid present in the tumor microenvironment can negate the pro apototic effect of a recombinant fragment of human surfactant protein d on breast cancer cells
topic innate immunity
surfactant protein D
immune surveillance
breast cancer
hyaluronic acid
url https://www.frontiersin.org/article/10.3389/fimmu.2020.01171/full
work_keys_str_mv AT valarmathymurugaiah hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT chiaraagostinis hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT praveenmvarghese hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT praveenmvarghese hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT beatricebelmonte hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT salvatorevieni hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT fananaalaql hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT salmanhalrokayan hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT haseebakhan hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT anuvinderkaur hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT terryroberts hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT tarunamadan hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT robertabulla hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells
AT udaykishore hyaluronicacidpresentinthetumormicroenvironmentcannegatetheproapototiceffectofarecombinantfragmentofhumansurfactantproteindonbreastcancercells